Publication Information

{'id': 'https://openalex.org/W2013806387', 'doi': 'https://doi.org/10.1185/03007995.2011.576236', 'title': 'Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study', 'display_name': 'Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study', 'publication_year': 2011, 'publication_date': '2011-05-10', 'ids': {'openalex': 'https://openalex.org/W2013806387', 'doi': 'https://doi.org/10.1185/03007995.2011.576236', 'mag': '2013806387', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21554144'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1185/03007995.2011.576236', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S206643269', 'display_name': 'Current Medical Research and Opinion', 'issn_l': '0300-7995', 'issn': ['0300-7995', '1473-4877'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5071142253', 'display_name': 'Hind T. Hatoum', 'orcid': 'https://orcid.org/0009-0000-2147-6954'}, 'institutions': [{'id': 'https://openalex.org/I39422238', 'display_name': 'University of Illinois Chicago', 'ror': 'https://ror.org/02mpq6x41', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39422238']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hind T. Hatoum', 'raw_affiliation_strings': ['Hind T. Hatoum & Company and Pharmacy Administration, The University of Illinois at Chicago,\rIL, USA'], 'affiliations': [{'raw_affiliation_string': 'Hind T. Hatoum & Company and Pharmacy Administration, The University of Illinois at Chicago,\rIL, USA', 'institution_ids': ['https://openalex.org/I39422238']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047931838', 'display_name': 'Swu–Jane Lin', 'orcid': 'https://orcid.org/0000-0003-0953-9988'}, 'institutions': [{'id': 'https://openalex.org/I39422238', 'display_name': 'University of Illinois Chicago', 'ror': 'https://ror.org/02mpq6x41', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39422238']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Swu-Jane Lin', 'raw_affiliation_strings': ['Pharmacy Administration, The University of Illinois at Chicago and Hind T. Hatoum & Company,\rChicago IL, USA'], 'affiliations': [{'raw_affiliation_string': 'Pharmacy Administration, The University of Illinois at Chicago and Hind T. Hatoum & Company,\rChicago IL, USA', 'institution_ids': ['https://openalex.org/I39422238']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104015501', 'display_name': 'Deborah Buchner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151718', 'display_name': 'Eisai (United States)', 'ror': 'https://ror.org/0469x1750', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151718', 'https://openalex.org/I55881946']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Deborah Buchner', 'raw_affiliation_strings': ['Eisai Inc.,\rWoodcliff Lake, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Eisai Inc.,\rWoodcliff Lake, NJ, USA', 'institution_ids': ['https://openalex.org/I4210151718']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5100728166', 'display_name': 'Edward Kim', 'orcid': 'https://orcid.org/0000-0002-8563-0823'}, 'institutions': [{'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Edward Kim', 'raw_affiliation_strings': ['Former employee of Eisai Inc., Woodcliff Lake, NY, USA'], 'affiliations': [{'raw_affiliation_string': 'Former employee of Eisai Inc., Woodcliff Lake, NY, USA', 'institution_ids': ['https://openalex.org/I55881946']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.368, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.607184, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 78, 'max': 80}, 'biblio': {'volume': '27', 'issue': '6', 'first_page': '1255', 'last_page': '1262'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11628', 'display_name': 'Myeloproliferative Neoplasms: Diagnosis and Treatment', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10554', 'display_name': 'Hemoglobinopathies and Related Disorders', 'score': 0.9938, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/azacitidine', 'display_name': 'Azacitidine', 'score': 0.9509522}, {'id': 'https://openalex.org/keywords/decitabine', 'display_name': 'Decitabine', 'score': 0.92877674}, {'id': 'https://openalex.org/keywords/hypomethylating-agent', 'display_name': 'Hypomethylating agent', 'score': 0.7963178}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.96117145}, {'id': 'https://openalex.org/C2776239401', 'wikidata': 'https://www.wikidata.org/wiki/Q416451', 'display_name': 'Azacitidine', 'level': 5, 'score': 0.9509522}, {'id': 'https://openalex.org/C2780235182', 'wikidata': 'https://www.wikidata.org/wiki/Q1181878', 'display_name': 'Decitabine', 'level': 5, 'score': 0.92877674}, {'id': 'https://openalex.org/C2780817109', 'wikidata': 'https://www.wikidata.org/wiki/Q954625', 'display_name': 'Myelodysplastic syndromes', 'level': 3, 'score': 0.9233499}, {'id': 'https://openalex.org/C2776012956', 'wikidata': 'https://www.wikidata.org/wiki/Q17125294', 'display_name': 'Hypomethylating agent', 'level': 5, 'score': 0.7963178}, {'id': 'https://openalex.org/C2780240888', 'wikidata': 'https://www.wikidata.org/wiki/Q6052586', 'display_name': 'International Prognostic Scoring System', 'level': 4, 'score': 0.48947036}, {'id': 'https://openalex.org/C2776063141', 'wikidata': 'https://www.wikidata.org/wiki/Q425681', 'display_name': 'Lenalidomide', 'level': 3, 'score': 0.4875955}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.47720867}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4173427}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.39638257}, {'id': 'https://openalex.org/C2780007613', 'wikidata': 'https://www.wikidata.org/wiki/Q546523', 'display_name': 'Bone marrow', 'level': 2, 'score': 0.09632948}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.07808906}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077209', 'descriptor_name': 'Decitabine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007345', 'descriptor_name': 'Insurance Claim Review', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1185/03007995.2011.576236', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S206643269', 'display_name': 'Current Medical Research and Opinion', 'issn_l': '0300-7995', 'issn': ['0300-7995', '1473-4877'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21554144', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.73, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1855038159', 'https://openalex.org/W1970101456', 'https://openalex.org/W1979144446', 'https://openalex.org/W2000445173', 'https://openalex.org/W2031826516', 'https://openalex.org/W2036068780', 'https://openalex.org/W2052822682', 'https://openalex.org/W2071289131', 'https://openalex.org/W2076225806', 'https://openalex.org/W2077208257', 'https://openalex.org/W2081279521', 'https://openalex.org/W2083307780', 'https://openalex.org/W2099071696', 'https://openalex.org/W2106584820', 'https://openalex.org/W2149982846', 'https://openalex.org/W2155296700', 'https://openalex.org/W2316392947', 'https://openalex.org/W2399266602', 'https://openalex.org/W2418357856', 'https://openalex.org/W4242962945', 'https://openalex.org/W4247972768'], 'related_works': ['https://openalex.org/W4245640489', 'https://openalex.org/W3203236595', 'https://openalex.org/W2559444916', 'https://openalex.org/W2557741488', 'https://openalex.org/W2436188093', 'https://openalex.org/W2409251897', 'https://openalex.org/W2096084875', 'https://openalex.org/W2054507167', 'https://openalex.org/W2051650123', 'https://openalex.org/W1983754555'], 'abstract_inverted_index': {'Objective:The': [0], 'purpose': [1], 'of': [2, 9, 19, 33], 'this': [3], 'study': [4], 'is': [5], 'to': [6, 15, 27], 'describe': [7], 'patterns': [8], 'hypomethylating': [10], 'agents': [11, 35], '(HMA)': [12], 'use': [13, 32], 'and': [14, 22, 30], 'compare': [16], 'treatment': [17, 37], 'outcomes': [18], 'decitabine': [20], '(DAC)': [21], 'azacitidine': [23], '(AZA)': [24], 'with': [25, 41], 'respect': [26], 'transfusion': [28], 'dependence': [29], 'the': [31], 'erythropoiesis-stimulating': [34], '(ESA)': [36], 'in': [38], 'commercially-insured': [39], 'patients': [40], 'Myelodysplastic': [42], 'Syndromes': [43], '(MDS).': [44]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2013806387', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-12-11T07:41:26.879670', 'created_date': '2016-06-24'}